- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 3rd, 2006
Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation medical technology, announced today that it has filed a U.S. patent application for the use of halloysite nanotubes for controlled release of drugs.
The technology utilizes halloysite nanotubes, which are being commercialized by NaturalNano, Inc. (OTCBB: NNAN; FWB: N3N). These nanotubes, which are hollow inorganic nanostructures derived from clay, allow the linear, controlled release of drugs.
|Related News Press|
Cellulose from wood can be printed in 3-D June 17th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Clues to inner atomic life from subtle light-emission shifts: Hyperfine structure of light absorption by short-lived cadmium atom isotopes reveals characteristics of the nucleus that matter for high precision detection methods July 3rd, 2015
High-tech nanofibres could help nutrients in food hit the spot June 17th, 2015